Cargando…

Detailed Insights into the Inhibitory Mechanism of New Ebselen Derivatives against Main Protease (M(pro)) of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)

[Image: see text] SARS-CoV-2 main protease (M(pro)/3CL(pro)) is a crucial target for therapeutics, which is responsible for viral polyprotein cleavage and plays a vital role in virus replication and survival. Recent studies suggest that 2-phenylbenzisoselenazol-3(2H)-one (ebselen) is a potent covale...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sahoo, Pritiranjan, Lenka, Dipti Ranjan, Batabyal, Monojit, Pain, Pritam Kumar, Kumar, Sangit, Manna, Debasish, Kumar, Atul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797022/ https://www.ncbi.nlm.nih.gov/pubmed/36650888 http://dx.doi.org/10.1021/acsptsci.2c00203

Ejemplares similares

Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease
por: Menéndez, Cintia A., et al.
Publicado: (2020)

Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives
por: Amporndanai, Kangsa, et al.
Publicado: (2021)

Electrochemical Biosensor for the Detection of SARS-CoV-2 Main Protease and Its Inhibitor Ebselen
por: Zhang, Qiongyu, et al.
Publicado: (2022)

Structure‐Activity Studies Reveal Scope for Optimisation of Ebselen‐Type Inhibition of SARS‐CoV‐2 Main Protease
por: Thun‐Hohenstein, Siegfried T. D., et al.
Publicado: (2021)

Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors
por: Ma, Chunlong, et al.
Publicado: (2020)

Exploring the simultaneous σ-hole/π-hole bonding characteristics of a Br⋯π interaction in an ebselen derivative via experimental and theoretical electron-density analysis
por: Shukla, Rahul, et al.
Publicado: (2018)

Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are non-specific promiscuous SARS-CoV-2 main protease inhibitors
por: Ma, Chunlong, et al.
Publicado: (2020)

The Se–S Bond Formation in the Covalent Inhibition Mechanism of SARS-CoV-2 Main Protease by Ebselen-like Inhibitors: A Computational Study
por: Parise, Angela, et al.
Publicado: (2021)

Antibacterial Activity of Ebselen
por: Maślanka, Marta, et al.
Publicado: (2023)

Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2
por: Weglarz-Tomczak, Ewelina, et al.
Publicado: (2021)

Melatonin and MitoEbselen-2 Are Radioprotective Agents to Mitochondria
por: Shimura, Tsutomu, et al.
Publicado: (2022)

Identification of bioactive molecules from Triphala (Ayurvedic herbal formulation) as potential inhibitors of SARS-CoV-2 main protease (Mpro) through computational investigations
por: Rudrapal, Mithun, et al.
Publicado: (2022)

Chlorhexidine and SARS-CoV-2 main protease: Molecular docking study
por: Grover, Vishakha, et al.
Publicado: (2022)

Insilico generation of novel ligands for the inhibition of SARS-CoV-2 main protease (3CL(pro)) using deep learning
por: Prabhakaran, Prejwal, et al.
Publicado: (2023)

Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2
por: Tripathi, Praveen Kumar, et al.
Publicado: (2020)

The role of herbal plants in the inhibition of SARS-CoV-2 main protease: A computational approach
por: Srivastava, Ambrish Kumar, et al.
Publicado: (2022)

Allosteric inhibitors of the main protease of SARS-CoV-2
por: Samrat, Subodh Kumar, et al.
Publicado: (2022)

The Potential Use of Ebselen in Treatment-Resistant Depression
por: Ramli, Fitri Fareez, et al.
Publicado: (2022)

Chemistry Related to the Catalytic Cycle of the Antioxidant Ebselen
por: Sands, Kai N., et al.
Publicado: (2023)

Theaflavin 3-gallate inhibits the main protease (M(pro)) of SARS-CoV-2 and reduces its count in vitro
por: Chauhan, Mahima, et al.
Publicado: (2022)

In Silico Identification and Validation of Organic Triazole Based Ligands as Potential Inhibitory Drug Compounds of SARS-CoV-2 Main Protease
por: Sur, Vishma Pratap, et al.
Publicado: (2021)

Ebselen, a new candidate therapeutic against SARS-CoV-2
por: Haritha, C.V., et al.
Publicado: (2020)

Insect protease inhibitors; promising inhibitory compounds against SARS-CoV-2 main protease
por: Hemmati, Seyed Ali, et al.
Publicado: (2022)

Factual insights of the allosteric inhibition mechanism of SARS-CoV-2 main protease by quercetin: an in silico analysis
por: Verma, Shalja, et al.
Publicado: (2021)

Analysis of SARS-CoV-2 mutations in the main viral protease (NSP5) and its implications on the vaccine designing strategies
por: Yashvardhini, Niti, et al.
Publicado: (2022)

Analysis of SARS-CoV-2 mutations in the main viral protease (NSP5) and its implications on the vaccine designing strategies
por: Yashvardhini, Niti, et al.
Publicado: (2022)

An insight into the interaction between α-ketoamide- based inhibitor and coronavirus main protease: A detailed in silico study
por: Banerjee, Snehasis
Publicado: (2021)

Ebselen oxide and derivatives are new allosteric HER2 inhibitors for HER2‐positive cancers
por: Blasquez, Lucas, et al.
Publicado: (2023)

Mechanistic investigation of SARS-CoV-2 main protease to accelerate design of covalent inhibitors
por: Kim, Hoshin, et al.
Publicado: (2022)

Interactions between main protease of SARS-CoV-2 and testosterone or progesterone using computational approach
por: Vishvakarma, Vijay Kumar, et al.
Publicado: (2022)

Spectroscopic details on the molecular structure of pyrimidine‑2‑thiones heterocyclic compounds: computational and antiviral activity against the main protease enzyme of SARS-CoV-2
por: Sayed, Doaa S. El, et al.
Publicado: (2022)

Computational investigation of natural compounds as potential main protease (M(pro)) inhibitors for SARS-CoV-2 virus
por: Patel, Chirag N., et al.
Publicado: (2022)

Mechanism of inhibition of Mycobacterium tuberculosis antigen 85 by ebselen
por: Favrot, Lorenza, et al.
Publicado: (2013)

Evaluation of ebselen supplementation on cryopreservation medium in human semen
por: Khodayari Naeini, Zohreh, et al.
Publicado: (2014)

Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections
por: Thangamani, Shankar, et al.
Publicado: (2015)

Convergent Synthesis of Two Fluorescent Ebselen-Coumarin Heterodimers
por: Küppers, Jim, et al.
Publicado: (2016)

Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE)
por: AbdelKhalek, Ahmed, et al.
Publicado: (2018)

New Chiral Ebselen Analogues with Antioxidant and Cytotoxic Potential
por: Pacuła, Agata J., et al.
Publicado: (2017)

Micelle-embedded coating with ebselen for nitric oxide generation
por: Yang, Li, et al.
Publicado: (2019)

Ebselen and Analogues: Pharmacological Properties and Synthetic Strategies for Their Preparation
por: Santi, Claudio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rr35lggo0jh31ihubdokvasjfs